{"id":"https://openalex.org/W2065463534","doi":"https://doi.org/10.1007/s40263-014-0164-4","title":"Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?","display_name":"Misuse and Abuse of Pregabalin and Gabapentin: Cause for Concern?","alternate_titles":[],"publication_year":2014,"publication_date":"2014-04-24","ids":{"openalex":"https://openalex.org/W2065463534","doi":"https://doi.org/10.1007/s40263-014-0164-4","mag":"2065463534","pmid":"https://pubmed.ncbi.nlm.nih.gov/24760436"},"language":"en","primary_location":{"id":"doi:10.1007/s40263-014-0164-4","doi":"https://doi.org/10.1007/s40263-014-0164-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-014-0164-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40263-014-0164-4.pdf","source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2065463534"],"child_works_count":0,"type":"editorial","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://link.springer.com/content/pdf/10.1007/s40263-014-0164-4.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078706372","display_name":"Fabrizio Schifano","orcid":"https://orcid.org/0000-0002-4178-5401","observed_orcids":["https://orcid.org/0000-0002-4178-5401"]},"institutions":[{"id":"https://openalex.org/I141584323","display_name":"University of Hertfordshire","ror":"https://ror.org/0267vjk41","country_code":"GB","type":"education","lineage":["https://openalex.org/I141584323"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Fabrizio Schifano","raw_affiliation_strings":["Chair in Clinical Pharmacology and Therapeutics, University of Hertfordshire, School of Life and Medical Sciences, College Lane Campus, Hatfield, AL10 9AB, UK, f.schifano@herts.ac.uk","University of Hertfordshire, School of Life and Medical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chair in Clinical Pharmacology and Therapeutics, University of Hertfordshire, School of Life and Medical Sciences, College Lane Campus, Hatfield, AL10 9AB, UK, f.schifano@herts.ac.uk","institution_ids":["https://openalex.org/I141584323"]},{"raw_affiliation_string":"University of Hertfordshire, School of Life and Medical Sciences","institution_ids":["https://openalex.org/I141584323"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5078706372"],"corresponding_institution_ids":["https://openalex.org/I141584323"],"apc_list":{"value":5090,"currency":"USD","value_usd":5090},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":279,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"6","first_page":"491","last_page":"496"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.975600004196167,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.01209999993443489,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pregabalin","display_name":"pregabalin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/gabapentin","display_name":"gabapentin","score":1.0},{"id":"https://openalex.org/keywords/gabapentinoids","display_name":"gabapentinoids","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.9679999947547913},{"id":"https://openalex.org/keywords/black-market","display_name":"black market","score":0.7300000190734863},{"id":"https://openalex.org/keywords/recreational-drug-use","display_name":"recreational drug use","score":0.7039999961853027},{"id":"https://openalex.org/keywords/calcium-channel-binding","display_name":"calcium channel binding","score":0.6819999814033508},{"id":"https://openalex.org/keywords/dopamine-reward-system","display_name":"dopaminergic reward system","score":0.9409999847412109},{"id":"https://openalex.org/keywords/drug-prescribing","display_name":"drug prescribing","score":0.5260000228881836},{"id":"https://openalex.org/keywords/medication-tapering","display_name":"medication tapering","score":0.5789999961853027}],"concepts":[{"id":"https://openalex.org/C2776468701","wikidata":"https://www.wikidata.org/wiki/Q412174","display_name":"Pregabalin","level":2,"score":0.9849356412887573},{"id":"https://openalex.org/C2776608144","wikidata":"https://www.wikidata.org/wiki/Q410352","display_name":"Gabapentin","level":3,"score":0.9192287921905518},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6348751783370972},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4508036971092224},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.41232356429100037},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3827180564403534},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.15643912553787231},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069583","descriptor_name":"Pregabalin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077206","descriptor_name":"Gabapentin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000588","descriptor_name":"Amines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D003509","descriptor_name":"Cyclohexanecarboxylic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D063487","descriptor_name":"Prescription Drug Misuse","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1007/s40263-014-0164-4","doi":"https://doi.org/10.1007/s40263-014-0164-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-014-0164-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40263-014-0164-4.pdf","source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},{"id":"pmid:24760436","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24760436","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS drugs","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s40263-014-0164-4","doi":"https://doi.org/10.1007/s40263-014-0164-4","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s40263-014-0164-4","pdf_url":"https://link.springer.com/content/pdf/10.1007/s40263-014-0164-4.pdf","source":{"id":"https://openalex.org/S153913659","display_name":"CNS Drugs","issn_l":"1172-7047","issn":["1172-7047","1179-1934"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Drugs","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2065463534.pdf","grobid_xml":"https://content.openalex.org/works/W2065463534.grobid-xml"},"referenced_works_count":48,"referenced_works":["https://openalex.org/W1245636391","https://openalex.org/W1509614296","https://openalex.org/W1584768094","https://openalex.org/W1720984727","https://openalex.org/W1908826089","https://openalex.org/W1973180535","https://openalex.org/W1977265431","https://openalex.org/W1977980816","https://openalex.org/W1981941375","https://openalex.org/W1992106585","https://openalex.org/W1992366653","https://openalex.org/W2002594874","https://openalex.org/W2006956448","https://openalex.org/W2008496020","https://openalex.org/W2009317359","https://openalex.org/W2009513529","https://openalex.org/W2028295001","https://openalex.org/W2033644828","https://openalex.org/W2038855331","https://openalex.org/W2039450042","https://openalex.org/W2041602951","https://openalex.org/W2043743770","https://openalex.org/W2044958137","https://openalex.org/W2052846837","https://openalex.org/W2055053420","https://openalex.org/W2058884859","https://openalex.org/W2061736723","https://openalex.org/W2062837533","https://openalex.org/W2069850786","https://openalex.org/W2082351404","https://openalex.org/W2088601889","https://openalex.org/W2090489905","https://openalex.org/W2102234164","https://openalex.org/W2103398398","https://openalex.org/W2126145291","https://openalex.org/W2144532061","https://openalex.org/W2149053054","https://openalex.org/W2150331361","https://openalex.org/W2152645546","https://openalex.org/W2154997364","https://openalex.org/W2162324028","https://openalex.org/W2165379966","https://openalex.org/W2175885176","https://openalex.org/W2399662290","https://openalex.org/W2404995465","https://openalex.org/W2410907696","https://openalex.org/W2916865606","https://openalex.org/W4300502925"],"related_works":["https://openalex.org/W3194144399","https://openalex.org/W3082895188","https://openalex.org/W2763928864","https://openalex.org/W4235783702","https://openalex.org/W6908700730","https://openalex.org/W2583970354","https://openalex.org/W4401225914","https://openalex.org/W4283066106","https://openalex.org/W2808824431","https://openalex.org/W2883276235"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2065463534","counts_by_year":[{"year":2026,"cited_by_count":11},{"year":2025,"cited_by_count":22},{"year":2024,"cited_by_count":14},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":34},{"year":2020,"cited_by_count":24},{"year":2019,"cited_by_count":32},{"year":2018,"cited_by_count":35},{"year":2017,"cited_by_count":23},{"year":2016,"cited_by_count":26},{"year":2015,"cited_by_count":23},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
